Lead Product(s) : SHR7280
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : SHR7280 is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Leiomyoma-associated with Menorrhagia.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 05, 2022
Lead Product(s) : SHR7280
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pentosan Polysulfate Sodium
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II/ Phase III
Sponsor : TCM Biotech International Corp.
Deal Size : Inapplicable
Deal Type : Inapplicable
Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial
Details : Pentosan Polysulfate Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Cystitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 18, 2022
Lead Product(s) : Pentosan Polysulfate Sodium
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II/ Phase III
Sponsor : TCM Biotech International Corp.
Deal Size : Inapplicable
Deal Type : Inapplicable